168 related articles for article (PubMed ID: 37368061)
1. Mapping from SIBDQ to EQ-5D-5L for patients with inflammatory bowel disease.
Steiner IM; Bokemeyer B; Stargardt T
Eur J Health Econ; 2024 Apr; 25(3):539-548. PubMed ID: 37368061
[TBL] [Abstract][Full Text] [Related]
2. The estimation of a preference-based single index for the IBS-QoL by mapping to the EQ-5D-5L in patients with irritable bowel syndrome.
Sturkenboom R; Keszthelyi D; Brandts L; Weerts ZZRM; Snijkers JTW; Masclee AAM; Essers BAB
Qual Life Res; 2022 Apr; 31(4):1209-1221. PubMed ID: 34546554
[TBL] [Abstract][Full Text] [Related]
3. Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data.
Neilson AR; Jones GT; Macfarlane GJ; Pathan EM; McNamee P
Eur J Health Econ; 2022 Nov; 23(8):1357-1369. PubMed ID: 35113270
[TBL] [Abstract][Full Text] [Related]
4. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.
Moore A; Young CA; Hughes DA
Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280
[TBL] [Abstract][Full Text] [Related]
5. Construct validity of EQ-5D-5L among patients with inflammatory bowel disease-a study based on real-world data from the Swedish Inflammatory Bowel Disease Registry.
Latteur J; Ernstsson O; Nilsson E; Jäghult S; Heintz E
J Patient Rep Outcomes; 2024 Mar; 8(1):39. PubMed ID: 38536626
[TBL] [Abstract][Full Text] [Related]
6. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.
Wong CKH; Cheung PWH; Samartzis D; Luk KD; Cheung KMC; Lam CLK; Cheung JPY
PLoS One; 2017; 12(4):e0175847. PubMed ID: 28414745
[TBL] [Abstract][Full Text] [Related]
7. Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores.
Meunier A; Soare A; Chevrou-Severac H; Myren KJ; Murata T; Longworth L
Appl Health Econ Health Policy; 2022 Jan; 20(1):119-131. PubMed ID: 34554442
[TBL] [Abstract][Full Text] [Related]
8. Mapping the kidney disease quality of life 36-item short form survey (KDQOL-36) to the EQ-5D-3L and the EQ-5D-5L in patients undergoing dialysis.
Yang F; Wong CKH; Luo N; Piercy J; Moon R; Jackson J
Eur J Health Econ; 2019 Nov; 20(8):1195-1206. PubMed ID: 31338698
[TBL] [Abstract][Full Text] [Related]
9. A mapping study in mainland China: predicting EQ-5D-5L utility scores from the psoriasis disability index.
Su J; Liu T; Li S; Zhao Y; Kuang Y
J Med Econ; 2020 Jul; 23(7):737-743. PubMed ID: 32223358
[No Abstract] [Full Text] [Related]
10. Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia.
Meregaglia M; Borsoi L; Cairns J; Tarricone R
Eur J Health Econ; 2019 Mar; 20(2):181-193. PubMed ID: 28948436
[TBL] [Abstract][Full Text] [Related]
11. Mapping Dermatology Life Quality Index (DLQI) scores to EQ-5D utility scores using data of patients with atopic dermatitis from the National Health and Wellness Study.
Vilsbøll AW; Kragh N; Hahn-Pedersen J; Jensen CE
Qual Life Res; 2020 Sep; 29(9):2529-2539. PubMed ID: 32297132
[TBL] [Abstract][Full Text] [Related]
12. Development of algorithms to estimate the EQ-5D-5L from the FACT-L in patients with lung cancer: a mapping study.
Jiang L; Zhou H; Yang Q; Luo X; Huang D
Qual Life Res; 2024 Mar; 33(3):805-816. PubMed ID: 38148367
[TBL] [Abstract][Full Text] [Related]
13. Do country-specific preference weights matter in the choice of mapping algorithms? The case of mapping the Diabetes-39 onto eight country-specific EQ-5D-5L value sets.
Lamu AN; Chen G; Gamst-Klaussen T; Olsen JA
Qual Life Res; 2018 Jul; 27(7):1801-1814. PubMed ID: 29569014
[TBL] [Abstract][Full Text] [Related]
14. Mapping MacNew Heart Disease Quality of Life Questionnaire onto country-specific EQ-5D-5L utility scores: a comparison of traditional regression models with a machine learning technique.
Gao L; Luo W; Tonmukayakul U; Moodie M; Chen G
Eur J Health Econ; 2021 Mar; 22(2):341-350. PubMed ID: 33438134
[TBL] [Abstract][Full Text] [Related]
15. Mapping of the EORTC QLQ-C30 to EQ-5D-5L index in patients with lymphomas.
Xu RH; Wong ELY; Jin J; Dou Y; Dong D
Eur J Health Econ; 2020 Dec; 21(9):1363-1373. PubMed ID: 32960388
[TBL] [Abstract][Full Text] [Related]
16. Does linear equating improve prediction in mapping? Crosswalking MacNew onto EQ-5D-5L value sets.
Lamu AN
Eur J Health Econ; 2020 Aug; 21(6):903-915. PubMed ID: 32300999
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease (IBD) patients with impaired quality of life on biologic therapy benefit from the support of an IBD nurse specialist: Results of a randomised controlled trial in Germany (IBD
Bokemeyer B; Plachta-Danielzik S; Steiner IM; Pohlschneider D; Urzica E; Hartmann P; Zemke J; Tappe U; Schreiber S; Steinkat N; Langbrandtner J; Hüppe A; Stargardt T
Aliment Pharmacol Ther; 2024 May; 59(9):1082-1095. PubMed ID: 38429885
[TBL] [Abstract][Full Text] [Related]
18. Mapping the Seattle Angina Questionnaire to EQ-5D-5L in patients with coronary heart disease.
Li C; Dou L; Fu Q; Li S
Health Qual Life Outcomes; 2023 Jul; 21(1):64. PubMed ID: 37400827
[TBL] [Abstract][Full Text] [Related]
19. Estimating Cost-Effectiveness Using Alternative Preference-Based Scores and Within-Trial Methods: Exploring the Dynamics of the Quality-Adjusted Life-Year Using the EQ-5D 5-Level Version and Recovering Quality of Life Utility Index.
Franklin M; Hunter RM; Enrique A; Palacios J; Richards D
Value Health; 2022 Jun; 25(6):1018-1029. PubMed ID: 35667775
[TBL] [Abstract][Full Text] [Related]
20. Enabling QALY estimation in mental health trials and care settings: mapping from the PHQ-9 and GAD-7 to the ReQoL-UI or EQ-5D-5L using mixture models.
Franklin M; Hernández Alava M
Qual Life Res; 2023 Oct; 32(10):2763-2778. PubMed ID: 37314661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
